Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 16/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4731066 | 0.92 | UTS2R (0.63) | UTS2RALDH1A1 | |
| SCHEMBL4730712 | 0.92 | UTS2R (0.61) | UTS2RSMN1; SMN2 | |
| SCHEMBL4733409 | 0.92 | UTS2R (0.61) | UTS2RSMN1; SMN2 | |
| SCHEMBL4730440 | 0.89 | UTS2R (0.65) | UTS2R | |
| SCHEMBL4731222 | 0.88 | UTS2R (0.64) | UTS2RMAPK1KDM4EALDH1A1HPGD | |
| SCHEMBL4730705 | 0.87 | UTS2R (0.65) | UTS2RMAPK1KDM4EALDH1A1HPGD | |
| SCHEMBL4732669 | 0.86 | UTS2R (0.60) | UTS2RSMN1; SMN2 | |
| SCHEMBL4731254 | 0.86 | UTS2R (0.60) | UTS2RSMN1; SMN2 | |
| SCHEMBL4731255 | 0.85 | UTS2R (0.56) | UTS2R | |
| SCHEMBL4729682 | 0.84 | UTS2R (0.64) | UTS2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008057543-A2 | UII-MODULATING COMPOUNDS AND THEIR USE | ACADIA PHARMACEUTICALS INC. (US) | 2008-05-15 | — | — | WO | claimed |
| WO-2008057543-A2 | UII-MODULATING COMPOUNDS AND THEIR USE | ACADIA PHARMACEUTICALS INC. (US) | 2008-05-15 | — | — | WO | disclosed |